UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Neville Rodie & Shaw Inc.

Neville Rodie & Shaw Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,763 shares of the healthcare conglomerate’s stock after selling 824 shares during the period. UnitedHealth Group comprises about 1.2% of Neville Rodie & Shaw Inc.’s investment portfolio, making the stock its 23rd biggest holding. Neville Rodie & Shaw Inc.’s holdings in UnitedHealth Group were worth $15,713,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently made changes to their positions in UNH. Texas Capital Bancshares Inc TX increased its position in UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after buying an additional 19 shares during the last quarter. Tealwood Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after acquiring an additional 19 shares during the last quarter. Atlas Private Wealth Advisors lifted its holdings in UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after purchasing an additional 19 shares during the last quarter. Prentice Wealth Management LLC grew its holdings in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after purchasing an additional 19 shares during the last quarter. Finally, Baker Avenue Asset Management LP lifted its stake in shares of UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after buying an additional 20 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $484.62 on Friday. The firm has a market cap of $446.04 billion, a price-to-earnings ratio of 29.62, a P/E/G ratio of 1.40 and a beta of 0.58. The stock’s fifty day simple moving average is $496.12 and its 200 day simple moving average is $504.71. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the company posted $6.26 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on UNH. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Morgan Stanley cut their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.